Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Rank in Stocks #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Share Price
$0.00244926
Market Cap
$51.67K
Change (1 day)
5.88%
Change (1 year)
110.15%
Country
GB
Trade Nuformix plc (NFX)

Category

Stock price history for Nuformix plc (NFX)
Highest end of day price: $0.00 on 2026-03-01

Lowest end of day price: $0.04 on 2015-12-01
Stock price history of Nuformix plc from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 411.32%
2024 -82.51%
2023 -11.70%
2022 -74.73%
2021 -56.41%
2020 -60.57%
2019 249.10%
2018 -26.41%
2017 -13.50%
2016 17.74%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$36.03 -48.65%
DK
$433.07 -13.83%
US
$737.71 16.02%
US
$298.91 66.79%
BE
$100.99 -36.10%
AU